MeSH term
Frequency | Condition_Probility | Adult | 8 | 0.0 |
Aged | 6 | 0.0 |
Aged, 80 and over | 3 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/genetics | 2 | 8.0 |
Cells, Cultured | 6 | 0.0 |
*DNA Methylation | 9 | 1.0 |
Female | 20 | 0.0 |
Humans | 43 | 0.0 |
Male | 16 | 0.0 |
Middle Aged | 9 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
*Promoter Regions (Genetics) | 5 | 0.0 |
Research Support, Non-U.S. Gov't | 29 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Adolescent | 5 | 0.0 |
Prospective Studies | 2 | 0.0 |
Biopsy | 2 | 0.0 |
Apoptosis/*physiology | 2 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*metabolism | 2 | 0.0 |
Hela Cells | 2 | 0.0 |
Mutation | 5 | 0.0 |
Phosphorylation | 4 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Transfection | 4 | 0.0 |
Ca(2+)-Calmodulin Dependent Protein Kinase/*genetics | 5 | 25.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Prognosis | 3 | 0.0 |
Time Factors | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
CpG Islands | 3 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Rabbits | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Amino Acid Sequence | 4 | 0.0 |
Animals | 13 | 0.0 |
*Apoptosis | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Reference Values | 2 | 0.0 |
Comparative Study | 3 | 0.0 |
Cytoskeletal Proteins/*metabolism | 2 | 1.0 |
Dystroglycans | 5 | 10.0 |
Dystrophin/*metabolism | 2 | 40.0 |
Immunohistochemistry | 6 | 0.0 |
Membrane Proteins/*metabolism | 2 | 0.0 |
Models, Biological | 2 | 0.0 |
Sarcoglycans | 4 | 16.0 |
Utrophin | 4 | 15.0 |
Calmodulin/metabolism | 2 | 4.0 |
*Dystrophin-Associated Proteins | 2 | 22.0 |
Electrophoresis, Polyacrylamide Gel | 2 | 0.0 |
Mice | 7 | 0.0 |
Muscular Dystrophies/metabolism | 2 | 40.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 3 | 0.0 |
Base Sequence | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Catalytic Domain | 2 | 0.0 |
Cell Line | 3 | 0.0 |
Gene Library | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
Child | 3 | 0.0 |
Child, Preschool | 3 | 0.0 |
English Abstract | 2 | 0.0 |
Pedigree | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Apoptosis/drug effects | 2 | 0.0 |
Survival Analysis | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Immunoblotting | 3 | 0.0 |
Rats | 2 | 0.0 |
Drug Therapy, Combination | 2 | 0.0 |
Antigens, CD26 | 3 | 11.0 |
Kinetics | 2 | 0.0 |
Histocytochemistry | 2 | 0.0 |
Models, Molecular | 2 | 0.0 |
B-Lymphocytes/enzymology | 2 | 5.0 |
T-Lymphocytes/enzymology | 2 | 5.0 |
Serine/chemistry | 2 | 1.0 |
Signal Transduction | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Gene Silencing | 2 | 0.0 |
Reproducibility of Results | 2 | 0.0 |
